ZIM Laboratories Limited (ZIMLAB.BO)
INR 85.47
(-0.13%)
INR 85.47
(-0.13%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.46 Billion INR | 30.81% |
| 2022 | 3.41 Billion INR | -0.01% |
| 2021 | 3.41 Billion INR | 5.19% |
| 2020 | 3.24 Billion INR | -0.16% |
| 2019 | 3.25 Billion INR | -0.96% |
| 2018 | 3.28 Billion INR | 10.11% |
| 2017 | 2.98 Billion INR | 15.14% |
| 2016 | 2.59 Billion INR | 1.14% |
| 2015 | 2.56 Billion INR | -3.38% |
| 2014 | 2.65 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 FY | 4.46 Billion INR | 30.81% |
| 2023 Q4 | 4.46 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 3.65 Billion INR | 0.0% |
| 2022 Q4 | 3.41 Billion INR | 0.0% |
| 2022 FY | 3.41 Billion INR | -0.01% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 3.44 Billion INR | 0.0% |
| 2021 Q2 | 3.22 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 3.41 Billion INR | 0.0% |
| 2021 FY | 3.41 Billion INR | 5.19% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q4 | 3.24 Billion INR | 0.0% |
| 2020 Q2 | 3.29 Billion INR | 0.0% |
| 2020 FY | 3.24 Billion INR | -0.16% |
| 2019 Q4 | 3.25 Billion INR | 0.0% |
| 2019 Q2 | 3.4 Billion INR | 0.0% |
| 2019 FY | 3.25 Billion INR | -0.96% |
| 2018 FY | 3.28 Billion INR | 10.11% |
| 2018 Q4 | 3.28 Billion INR | 0.0% |
| 2018 Q2 | 3.22 Billion INR | 0.0% |
| 2017 Q4 | 2.98 Billion INR | 0.0% |
| 2017 FY | 2.98 Billion INR | 15.14% |
| 2016 FY | 2.59 Billion INR | 1.14% |
| 2015 FY | 2.56 Billion INR | -3.38% |
| 2014 FY | 2.65 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | 93.068% |
| Aurobindo Pharma Limited | 450.71 Billion INR | 99.009% |
| Glenmark Life Sciences Limited | 28.5 Billion INR | 84.324% |
| Granules India Limited | 55.2 Billion INR | 91.907% |
| Indoco Remedies Limited | 21.44 Billion INR | 79.167% |
| Achyut Healthcare Limited | 309.52 Million INR | -1343.588% |
| Ajanta Pharma Limited | 46.38 Billion INR | 90.367% |
| Alkem Laboratories Limited | 155.74 Billion INR | 97.131% |
| Alpa Laboratories Limited | 1.82 Billion INR | -144.671% |
| Brooks Laboratories Limited | 904.45 Million INR | -394.024% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | 58.552% |
| Bajaj HealthCare Limited | 7.65 Billion INR | 41.602% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | 63.19% |
| Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 98.847% |
| Eris Lifesciences Limited | 70.48 Billion INR | 93.661% |
| FDC Limited | 24.68 Billion INR | 81.896% |
| Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 96.888% |
| Gufic Biosciences Limited | 10.92 Billion INR | 59.102% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | 61.65% |
| Ipca Laboratories Limited | 111.01 Billion INR | 95.975% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -105.835% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -150.778% |
| Lasa Supergenerics Limited | 1.5 Billion INR | -196.166% |
| Laurus Labs Limited | 83.87 Billion INR | 94.672% |
| Lupin Limited | 239.97 Billion INR | 98.138% |
| Mankind Pharma Limited | 119.63 Billion INR | 96.265% |
| Medicamen Biotech Limited | 2.94 Billion INR | -51.711% |
| Medico Remedies Limited | 961.95 Million INR | -364.495% |
| Megasoft Limited | 3.65 Billion INR | -22.116% |
| NATCO Pharma Limited | 69.06 Billion INR | 93.53% |
| Piramal Pharma Limited | 153.11 Billion INR | 97.082% |
| RPG Life Sciences Limited | 5.12 Billion INR | 12.878% |
| Sigachi Industries Limited | 6.94 Billion INR | 35.631% |
| Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 99.477% |
| Suven Pharmaceuticals Limited | 22.54 Billion INR | 80.177% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | -10.418% |
| Unichem Laboratories Limited | 31.69 Billion INR | 85.902% |
| Wanbury Limited | 3.43 Billion INR | -30.082% |
| Windlas Biotech Limited | 6.26 Billion INR | 28.646% |
| Zydus Lifesciences Limited | 292.8 Billion INR | 98.474% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | 13.245% |
| Divi's Laboratories Limited | 154.7 Billion INR | 97.112% |
| Hester Biosciences Limited | 6.62 Billion INR | 32.54% |
| Procter & Gamble Health Limited | 7.94 Billion INR | 43.751% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | -21.793% |
| Bal Pharma Limited | 3.2 Billion INR | -39.462% |
| Strides Pharma Science Limited | 58.39 Billion INR | 92.349% |
| Venus Remedies Limited | 6.26 Billion INR | 28.717% |
| Aarti Pharmalabs Limited | 25.82 Billion INR | 82.695% |
| Nectar Lifesciences Limited | 21.91 Billion INR | 79.607% |
| Shilpa Medicare Limited | 30.93 Billion INR | 85.555% |
| Aarti Drugs Limited | 24.32 Billion INR | 81.63% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | 80.092% |
| Suven Life Sciences Limited | 2.84 Billion INR | -56.833% |
| Ind-Swift Limited | 6.54 Billion INR | 31.728% |
| Valiant Laboratories Limited | 3.42 Billion INR | -30.388% |
| J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 88.813% |
| Solara Active Pharma Sciences Limited | 23.5 Billion INR | 80.994% |
| Themis Medicare Limited | 5.66 Billion INR | 21.114% |
| Hikal Limited | 24.87 Billion INR | 82.035% |
| Torrent Pharmaceuticals Limited | 150.61 Billion INR | 97.033% |
| Sequent Scientific Limited | 15.4 Billion INR | 70.993% |
| Novartis India Limited | 9.24 Billion INR | 51.691% |
| Wockhardt Limited | 76.49 Billion INR | 94.158% |
| Jubilant Pharmova Limited | 115.48 Billion INR | 96.131% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -849.016% |
| Neuland Laboratories Limited | 18.32 Billion INR | 75.618% |
| Morepen Laboratories Limited | 12.93 Billion INR | 65.448% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | -86.128% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | -34.01% |